知搜-全球专利检索

  1. Login
  2. Sign Up

Search Results

93 records (took 0.03 seconds)

    OSD system having colorful and dynamic OSD menu and method for controlling same
    41.
    发明申请
    OSD system having colorful and dynamic OSD menu and method for controlling same 审中-公开
    OSD系统具有丰富多彩的动态OSD菜单及其控制方法

    公开(公告)号：US20080239149A1

    公开(公告)日：2008-10-02

    申请号：US12080014

    申请日：2008-03-31

    Applicant: Jing-Zhou Lai ,  Hu-Da Gu La ,  Kuang-Liang Huang ,  Chun-Rong Song

    Inventor： Jing-Zhou Lai ,  Hu-Da Gu La ,  Kuang-Liang Huang ,  Chun-Rong Song

    IPC: H04N5/50

    CPC classification number: H04N5/44513 ,  H04N21/4122 ,  H04N21/4143 ,  H04N21/4312

    Abstract: An exemplary on-screen display (OSD) system (3) includes a display device (5) and a computer (4) connected to the display device. The display device includes a micro processing unit (MPU) (532) configured for providing a plurality of instruction signals according to external instructions. The computer includes a memory (41) and a central processing unit (CPU) (42). The memory includes an external OSD unit (412) configured for generating an external OSD menu. The external OSD menu is colorful and dynamic. The CPU is configured for identifying the instruction signals from the MPU and providing control signals corresponding to the instruction signals. The external OSD unit is capable of setting and assigning data to generate the external OSD menu on receiving the control signals from the CPU, whereupon the external OSD menu is displayed on the display device.

    Abstract translation: 示例性屏幕显示（OSD）系统（3）包括显示设备（5）和连接到显示设备的计算机（4）。 显示装置包括：微处理单元（MPU）（532），被配置为根据外部指令提供多个指令信号。 计算机包括存储器（41）和中央处理单元（CPU）（42）。 存储器包括被配置用于生成外部OSD菜单的外部OSD单元（412）。 外部OSD菜单丰富多彩，动态。 CPU被配置为从MPU识别指令信号并提供与指令信号相对应的控制信号。 外部OSD单元能够设置和分配数据以在从CPU接收控制信号时产生外部OSD菜单，于是在显示设备上显示外部OSD菜单。

    Methods for deriving, isolating, and/or extracting amino acid compositions from Fenugreek seed
    42.
    发明申请
    Methods for deriving, isolating, and/or extracting amino acid compositions from Fenugreek seed 有权
    从葫芦巴种子得到，分离和/或提取氨基酸组合物的方法

    公开(公告)号：US20050238738A1

    公开(公告)日：2005-10-27

    申请号：US11069747

    申请日：2005-03-01

    Applicant: Steve Lee ,  Richard Hynson ,  Ke-Qin Zhang ,  Wu-Zhou Li ,  Jing Zhou

    Inventor： Steve Lee ,  Richard Hynson ,  Ke-Qin Zhang ,  Wu-Zhou Li ,  Jing Zhou

    IPC: A61K36/286 ,  A61K36/48 ,  A61K36/55 ,  A61K36/88 ,  A61K36/8962 ,  A61K36/9066 ,  A61K35/78

    CPC classification number: A61K36/48 ,  A61K36/286 ,  A61K36/55 ,  A61K36/88 ,  A61K36/8962 ,  A61K36/9066 ,  A61K2300/00

    Abstract: The present invention is directed to novel compositions of bio-active compounds comprising 4-hydroxyisoleucine and one or more compounds selected from the group of amino acids, alkaloids, glycosides, volatile oils, saponins, sapogenins, mannans, flavonoids, fatty acids, vitamins and provitamins, minerals, and carbohydrates. Preferably, the novel compositions of bio-active compounds include 4-hydroxyisoleucine and one or more amino acids selected from the group consisting of arginine, aspartate, threonine, serine, glutamate, proline, glycine, alanine, cysteine, valine, methionine, isoleucine, leucine, tryptophan, phenylalanine, ornithine, proline, lysine, histidine, and gamma-aminobutyrate. The composition of bio-active compounds preferably include between about ten percent and about seventy percent of 4-hydroxyisoleucine and between about twenty percent and about forty percent of other amino acids. The bio-active compounds of the novel composition of the present invention may be derived, isolated, and/or extracted from Fenugreek seeds. A preferred method for extracting the bio-active compounds from Fenugreek seeds includes the steps of: (1) providing a plurality of Fenugreek seeds; (2) preparing the Fenugreek seeds; and (3) extracting a novel composition of bio-active compounds from the Fenugreek seeds, which include a preliminary extraction step and a secondary extraction step. The compositions of bio-active compounds have been found to be helpful in restoring healthy energy balance in humans and animals, aiding in weight management efforts, and for balancing blood sugar levels by way of assisting the body to make more efficient use of existing (i.e., endogenous) insulin.

    Abstract translation: 本发明涉及包含4-羟基异亮氨酸和一种或多种选自氨基酸，生物碱，糖苷，挥发性油，皂角苷，皂甙元，甘露聚糖，类黄酮，脂肪酸，维生素和/或其中的一种或多种化合物的生物活性化合物的新组合物， 维生素，矿物质和碳水化合物。 优选地，生物活性化合物的新组合物包括4-羟基异亮氨酸和一种或多种选自精氨酸，天冬氨酸，苏氨酸，丝氨酸，谷氨酸，脯氨酸，甘氨酸，丙氨酸，半胱氨酸，缬氨酸，甲硫氨酸，异亮氨酸， 亮氨酸，色氨酸，苯丙氨酸，鸟氨酸，脯氨酸，赖氨酸，组氨酸和γ-氨基丁酸。 生物活性化合物的组合物优选包括约10％至约70％的4-羟基异亮氨酸和约20％至约40％的其它氨基酸。 本发明的新型组合物的生物活性化合物可以从胡芦巴种子中衍生，分离和/或提取。 从葫芦巴种子提取生物活性化合物的优选方法包括以下步骤：（1）提供多种葫芦巴种子; （2）准备葫芦巴种子; （3）从葫芦巴种子中提取生物活性化合物的新组合物，其中包括初步提取步骤和二次提取步骤。 已经发现生物活性化合物的组合有助于恢复人和动物中的健康能量平衡，帮助体重管理工作，以及通过协助身体更有效地利用现有的（例如， ，内源性）胰岛素。

    Methods for enhancing the transport of glucose for balancing blood sugar levels
    43.
    发明申请
    Methods for enhancing the transport of glucose for balancing blood sugar levels 审中-公开
    用于增强血糖运输以平衡血糖水平的方法

    公开(公告)号：US20050233013A1

    公开(公告)日：2005-10-20

    申请号：US11068734

    申请日：2005-03-01

    Applicant: Steve Lee ,  Richard Hynson ,  Ke-Qin Zhang ,  Wu-Zhou Li ,  Jing Zhou

    Inventor： Steve Lee ,  Richard Hynson ,  Ke-Qin Zhang ,  Wu-Zhou Li ,  Jing Zhou

    IPC: A61K31/198 ,  A61K31/401 ,  A61K31/405 ,  A61K31/4172 ,  A61K35/78

    CPC classification number: A61K31/401 ,  A61K31/202 ,  A61K31/40 ,  A61K31/404 ,  A61K31/405 ,  A61K31/4172 ,  A61K31/436 ,  A61K31/44 ,  A61K31/4425 ,  A61K31/445 ,  A61K31/495 ,  A61K36/48 ,  A61K45/06 ,  A61K2236/39 ,  A61K31/198 ,  A61K2300/00

    Abstract: The present invention is directed to novel compositions of bio-active compounds comprising 4-hydroxyisoleucine and one or more compounds selected from the group of amino acids, alkaloids, glycosides, volatile oils, saponins, sapogenins, mannans, flavonoids, fatty acids, vitamins and provitamins, minerals, and carbohydrates. Preferably, the novel compositions of bio-active compounds include 4-hydroxyisoleucine and one or more amino acids selected from the group consisting of arginine, aspartate, threonine, serine, glutamate, proline, glycine, alanine, cysteine, valine, methionine, isoleucine, leucine, tryptophan, phenylalanine, ornithine, proline, lysine, histidine, and gamma-aminobutyrate. The composition of bio-active compounds preferably include between about ten percent and about seventy percent of 4-hydroxyisoleucine and between about twenty percent and about forty percent of other amino acids. The bio-active compounds of the novel composition of the present invention may be derived, isolated, and/or extracted from Fenugreek seeds. A preferred method for extracting the bio-active compounds from Fenugreek seeds includes the steps of: (1) providing a plurality of Fenugreek seeds; (2) preparing the Fenugreek seeds; and (3) extracting a novel composition of bio-active compounds from the Fenugreek seeds, which include a preliminary extraction step and a secondary extraction step. The compositions of bio-active compounds have been found to be helpful in restoring healthy energy balance in humans and animals, aiding in weight management efforts, and for balancing blood sugar levels by way of assisting the body to make more efficient use of existing (i.e., endogenous) insulin.

    Abstract translation: 本发明涉及包含4-羟基异亮氨酸和一种或多种选自氨基酸，生物碱，糖苷，挥发性油，皂角苷，皂甙元，甘露聚糖，类黄酮，脂肪酸，维生素和/或其中的一种或多种化合物的生物活性化合物的新组合物， 维生素，矿物质和碳水化合物。 优选地，生物活性化合物的新组合物包括4-羟基异亮氨酸和一种或多种选自精氨酸，天冬氨酸，苏氨酸，丝氨酸，谷氨酸，脯氨酸，甘氨酸，丙氨酸，半胱氨酸，缬氨酸，甲硫氨酸，异亮氨酸， 亮氨酸，色氨酸，苯丙氨酸，鸟氨酸，脯氨酸，赖氨酸，组氨酸和γ-氨基丁酸。 生物活性化合物的组成优选包括约10％至约70％的4-羟基异亮氨酸和约20％至约40％的其它氨基酸。 本发明的新型组合物的生物活性化合物可以从胡芦巴种子中衍生，分离和/或提取。 从葫芦巴种子提取生物活性化合物的优选方法包括以下步骤：（1）提供多种葫芦巴种子; （2）准备葫芦巴种子; （3）从葫芦巴种子中提取生物活性化合物的新组合物，其中包括初步提取步骤和二次提取步骤。 已经发现生物活性化合物的组合有助于恢复人和动物中的健康能量平衡，帮助体重管理工作，以及通过协助身体更有效地利用现有的（例如， ，内源性）胰岛素。

    System for character preserving guidelines removal in optically scanned text
    45.
    发明授权
    System for character preserving guidelines removal in optically scanned text 失效
    用于在光学扫描文本中删除字符的系统

    公开(公告)号：US5859929A

    公开(公告)日：1999-01-12

    申请号：US566002

    申请日：1995-12-01

    Applicant: Jing Zhou ,  Yang He

    Inventor： Jing Zhou ,  Yang He

    IPC: G06K9/34 ,  G06K9/48

    CPC classification number: G06K9/346 ,  G06K2209/01

    Abstract: An efficient system and method for reliably identifying guidelines, ruled lines, and the like, in images of text, and distinguishing those portions of such lines which touch or intersect character strokes in the image. The system provides for removal of guideline segments between character strokes without deleting character strokes. The system operates effectively on both machine printed and hand formed text. An image of text has most characters separated for more effective subsequent OCR processing, despite the presence of guidelines connecting the characters.

    Abstract translation: 一种用于在文本图像中可靠地识别准则，划线等的有效系统和方法，并且区分与图像中的字符笔触相接触或相交的那些部分。 该系统提供在字符笔划之间移除指南段而不删除字符笔画。 该系统在机器打印和手工制作文本上均有效地运行。 尽管存在连接字符的指南，文本的图像具有大多数字符分隔，用于更有效的后续OCR处理。

    Collagen COL4A6: gene, protein and method of detecting collagen deficiency
    46.
    发明授权
    Collagen COL4A6: gene, protein and method of detecting collagen deficiency 失效
    胶原蛋白COL4A6：基因，蛋白质和检测胶原蛋白缺乏症的方法

    公开(公告)号：US5731192A

    公开(公告)日：1998-03-24

    申请号：US494168

    申请日：1995-06-23

    Applicant: Stephen T. Reeders ,  Jing Zhou

    Inventor： Stephen T. Reeders ,  Jing Zhou

    IPC: A61K38/00 ,  C07K14/78 ,  C12N15/12 ,  C12N15/63 ,  C07H21/04

    CPC classification number: C07K14/78 ,  A61K38/00

    Abstract: A type IV collagen polynucleotide molecule, COL4A6, encoding .alpha.6(IV) polypeptide molecule, is identified on the X chromosome and expressed particularly in basement membranes. Genetic alteration of COL4A6 is associated with Alport's syndrome, a disease of basement membranes. Assays which detect an alteration of collagen .alpha.6(IV), or the polynucleotide molecules encoding it, are useful in determining pathologies associated with Alport's syndrome.

    Abstract translation: 编码α6（IV）多肽分子的IV型胶原多核苷酸分子COL4A6在X染色体上鉴定，特别是在基底膜中表达。 COL4A6的遗传改变与Alport综合征（基底膜疾病）有关。 检测胶原α6（IV）或其编码的多核苷酸分子的改变的测定可用于确定与Alport综合征相关的病理学。

    Direct inkjet fabrication of drug delivery devices
    49.
    发明授权
    Direct inkjet fabrication of drug delivery devices 有权
    药物输送装置的直接喷墨制造

    公开(公告)号：US09381154B2

    公开(公告)日：2016-07-05

    申请号：US13156503

    申请日：2011-06-09

    Applicant: Jing Zhou ,  Shu Chang

    Inventor： Jing Zhou ,  Shu Chang

    IPC: A61K9/20 ,  C09D11/34 ,  A61K9/00 ,  A61K9/24

    CPC classification number: A61K9/0056 ,  A61K9/209 ,  A61K9/2095 ,  B33Y30/00 ,  B33Y80/00

    Abstract: In some aspects of the present application, a method of forming one or more layers of at least a portion of a drug delivery device (DDD) is described. The method can include providing a substrate; providing one or more DDD components that are dissolved or dispersed in one or more pharmaceutically compatible phase change inks; ejecting, by one or more nozzles, a first portion of the one or more pharmaceutically compatible phase change inks to form a first layer on the substrate; and ejecting, by the one or more nozzles, a second portion of the pharmaceutically compatible phase change inks to form a second layer over the first layer.

    Abstract translation: 在本申请的一些方面，描述了形成药物递送装置（DDD）的至少一部分的一个或多个层的方法。 该方法可以包括提供基底; 提供溶解或分散在一种或多种药学上相容的相变油墨中的一种或多种DDD组分; 通过一个或多个喷嘴喷射所述一种或多种药学上相容的相变油墨的第一部分以在所述基底上形成第一层; 以及通过所述一个或多个喷嘴喷射所述药学上相容的相变油墨的第二部分，以在所述第一层上形成第二层。

Patent Agency Ranking